Karachi (Digital Post) Karachi A recent report by the Director General Audit has uncovered serious financial and administrative irregularities in the procurement of medicines at the Sindh Institute of Cardiovascular Diseases, Karachi.

Karachi (Digital Post) Karachi A recent report by the Director General Audit has uncovered serious financial and administrative irregularities in the procurement of medicines at the Sindh Institute of Cardiovascular Diseases, Karachi.

According to the audit findings, medicines worth 203.61 million rupees were delivered with significant delay. Under the contractual terms, the supplier was bound to provide medicines within five days. In case of non compliance, the order was to be cancelled, the supplier blacklisted, and the security deposit forfeited. The audit notes that none of these actions were taken.

The report further reveals that invoices and delivery challans did not mention the manufacturing and expiry dates. No joint inspection of medicines was conducted. No security deposit was obtained from the supplier. No written explanation was sought for the delay.

These lapses surfaced at a time when cardiac patients were facing an acute shortage of life saving drugs. The audit raises concerns of possible administrative favoritism toward the supplier for personal or financial interests.
The report also points to alleged misuse of authority by Chief Operating Officer Mr Musa Memon and recommends a transparent inquiry. It describes the case as a complete failure of the procurement and contract management system.